Back to search
Pulmonary Hypertension (World Health Organization Group 2)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Hypertension (World Health Organization Group 2) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Hypertension (World Health Organization Group 2) trials you may qualify forThis study is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart fai…
This is a placebo-controlled, double-blind, parallel, randomized, two-part, dose-confirming clinical study characterizing the pharmacodynamic effects of pulsed…
The objective of this exploratory study is to examine the utility of high resolution computed tomography (HRCT) to measure changes in functional pulmonary imagi…